{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:08:01Z","timestamp":1791994081535,"version":"4.4.0"},"reference-count":97,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["LIDER\/29\/60\/L-2\/10\/NCBiR\/2011"],"award-info":[{"award-number":["LIDER\/29\/60\/L-2\/10\/NCBiR\/2011"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["SONATA BIS NCN\/2012\/07\/E\/NZ7\/01269"],"award-info":[{"award-number":["SONATA BIS NCN\/2012\/07\/E\/NZ7\/01269"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["ETIUDA NCN\/2015\/16\/T\/NZ7\/00052"],"award-info":[{"award-number":["ETIUDA NCN\/2015\/16\/T\/NZ7\/00052"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["KNOW scholarship for N.Malek, statutory funds"],"award-info":[{"award-number":["KNOW scholarship for N.Malek, statutory funds"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2016.00257","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T23:36:47Z","timestamp":1471390607000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems\u2014A Novel Treatment Option for Chronic Pain Management"],"prefix":"10.3389","volume":"7","author":[{"given":"Natalia","family":"Malek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Starowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1021\/cr0782067","article-title":"Enzymatic pathways that regulate endocannabinoid signaling in the nervous system","volume":"108","author":"Ahn","year":"2008","journal-title":"Chem. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1124\/jpet.111.180257","article-title":"Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain","volume":"338","author":"Ahn","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201600111","article-title":"TRPV1-FAAH-COX: the couples game in pain treatment","author":"Aiello","year":"2016","journal-title":"ChemMedChem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3899\/jrheum.100748","article-title":"Safety advantages of topical versus oral nonsteroidal antiinflammatory drugs","volume":"38","author":"Altman","year":"2011","journal-title":"J. Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.brainresbull.2005.07.001","article-title":"TRPV1 desensitisation and endogenous vanilloid involvement in the enhanced analgesia induced by capsaicin in inflamed tissues","volume":"67","author":"Baamonde","year":"2005","journal-title":"Brain Res. Bull."},{"key":"B6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1381612023395655","article-title":"Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications","volume":"8","author":"Bisogno","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"B7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.pain.2005.06.024","article-title":"Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice","volume":"117","author":"B\u00f6lcskei","year":"2005","journal-title":"Pain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0304-3959(79)90046-0","article-title":"The need of a taxonomy","volume":"6","author":"Bonica","year":"1979","journal-title":"Pain"},{"key":"B9","first-page":"297","article-title":"Systems approaches to polypharmacology and drug discovery","volume":"13","author":"Boran","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"B10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.tips.2015.08.010","article-title":"Polypharmacology shakes hands with complex aetiopathology","volume":"36","author":"Brodie","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/j.gastro.2005.06.018","article-title":"Fatty acid amide hydrolase controls mouse intestinal motility in vivo","volume":"129","author":"Capasso","year":"2005","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/sj.bjp.0706699","article-title":"Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms","volume":"148","author":"Chang","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.phrs.2010.02.001","article-title":"The dual fatty acid amide hydrolase\/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice","volume":"61","author":"Costa","year":"2010","journal-title":"Pharmacol. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.neuroscience.2006.02.074","article-title":"Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain","volume":"139","author":"Cristino","year":"2006","journal-title":"Neuroscience"},{"key":"B15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"Csermely","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/35012076","article-title":"Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia","volume":"405","author":"Davis","year":"2000","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bcp.2005.05.011","article-title":"Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels","volume":"70","author":"De Lago","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.neuropharm.2008.06.023","article-title":"The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats","volume":"55","author":"De Novellis","year":"2008","journal-title":"Neuropharmacology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1744-8069-7-7","article-title":"The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats","volume":"7","author":"De Novellis","year":"2011","journal-title":"Mol. Pain"},{"key":"B20","doi-asserted-by":"publisher","first-page":"12856","DOI":"10.1074\/jbc.M008555200","article-title":"The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism","volume":"276","author":"De Petrocellis","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0006-2952(93)90486-G","article-title":"Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist","volume":"46","author":"Deutsch","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.pain.2012.06.016","article-title":"Inhibitors of endocannabinoid breakdown for pain: not so FA(AH)cile, after all","volume":"153","author":"Di Marzo","year":"2012","journal-title":"Pain"},{"key":"B23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0014-2999(00)00687-7","article-title":"Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide","volume":"406","author":"Di Marzo","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MOL.0b013e32803dbdec","article-title":"Endocannabinoids and the regulation of their levels in health and disease","volume":"18","author":"Di Marzo","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/sj.bjp.0707379","article-title":"The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action","volume":"152","author":"Fowler","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1006\/abbi.1998.1025","article-title":"Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen","volume":"362","author":"Fowler","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"B27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1476-5381.2008.00029.x","article-title":"The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1","volume":"156","author":"Fowler","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/1475636031000080216","article-title":"Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin","volume":"18","author":"Fowler","year":"2003","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.apmr.2007.12.003","article-title":"Chronic pain and opiates: balancing pain control and risks in long-term opioid treatment","volume":"89","author":"Gallagher","year":"2008","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"B30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pain.2008.01.024","article-title":"Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans","volume":"136","author":"Gavva","year":"2008","journal-title":"Pain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.pbb.2014.07.008","article-title":"Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models","volume":"124","author":"Grim","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B32","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.neuropharm.2005.12.002","article-title":"Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain","volume":"50","author":"Guindon","year":"2006","journal-title":"Neuropharmacology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pain.2005.12.007","article-title":"Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain","volume":"121","author":"Guindon","year":"2006","journal-title":"Pain"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/bjp.2008.41","article-title":"A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism","volume":"153","author":"Guindon","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.phrs.2012.10.013","article-title":"Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment","volume":"67","author":"Guindon","year":"2013","journal-title":"Pharmacol. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/sj.bjp.0706348","article-title":"Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors","volume":"146","author":"Holt","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pain.2007.04.032","article-title":"The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level","volume":"134","author":"Horvath","year":"2008","journal-title":"Pain"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/bjp.2008.33","article-title":"Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity","volume":"153","author":"Hu","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","article-title":"An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"B40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pharmthera.2009.06.008","article-title":"Lipids as targets for novel anti-inflammatory therapies","volume":"124","author":"Huwiler","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2174\/0929867311320130013","article-title":"Rationally Designed Multitarget Agents Against Inflammation and Pain","volume":"20","author":"Hwang","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12990-015-0004-7","article-title":"Peripherally increased artemin is a key regulator of TRPA1\/V1 expression in primary afferent neurons","volume":"8","author":"Ikeda-Miyagawa","year":"2015","journal-title":"Mol. Pain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.semcdb.2006.09.004","article-title":"The TRPV1 receptor and nociception","volume":"17","author":"Immke","year":"2006","journal-title":"Semin. Cell Dev. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0168-0102(01)00289-9","article-title":"Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin","volume":"41","author":"Ito","year":"2001","journal-title":"Neurosci. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/sj.bjp.0707433","article-title":"Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain","volume":"152","author":"Jhaveri","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"13318","DOI":"10.1523\/JNEUROSCI.3326-06.2006","article-title":"Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain","volume":"26","author":"Jhaveri","year":"2006","journal-title":"J. Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuropharm.2008.04.018","article-title":"Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain","volume":"55","author":"Jhaveri","year":"2008","journal-title":"Neuropharmacology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1211\/jpp.58.4.0008","article-title":"Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin","volume":"58","author":"Kanai","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1172\/JCI20449","article-title":"Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control","volume":"113","author":"Karai","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2174\/187152711796234989","article-title":"Fatty acid amide hydrolase inhibitors-progress and potential","volume":"10","author":"Khanna","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B52","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1124\/jpet.109.155465","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain","volume":"330","author":"Kinsey","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"44877","DOI":"10.1074\/jbc.M206788200","article-title":"Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides","volume":"277","author":"Kozak","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pain.2012.10.009","article-title":"Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate","volume":"154","author":"La Porta","year":"2013","journal-title":"Pain"},{"key":"B55","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1517\/13543776.2015.1008449","article-title":"Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014)","volume":"25","author":"Lee","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"B56","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.pain.2011.02.034","article-title":"A FAAH-fetched approach to treat osteoarthritis pain","volume":"152","author":"Lichtman","year":"2011","journal-title":"Pain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1124\/jpet.104.069401","article-title":"Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity","volume":"311","author":"Lichtman","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1124\/mol.105.015644","article-title":"Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1","volume":"69","author":"Lizanecz","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/npp.2014.198","article-title":"Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain","volume":"40","author":"Lomazzo","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1124\/jpet.105.093286","article-title":"Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors","volume":"316","author":"Maione","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.phrs.2013.07.003","article-title":"Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as \u201cdual-target\u201d analgesics","volume":"76","author":"Maione","year":"2013","journal-title":"Pharmacol. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/sj.bjp.0707145","article-title":"Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors","volume":"150","author":"Maione","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.phrs.2016.06.012","article-title":"The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain","volume":"111","author":"Malek","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/j.pain.0000000000000132","article-title":"A multi-target approach for pain treatment - dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis","volume":"156","author":"Malek","year":"2015a","journal-title":"Pain."},{"key":"B65","doi-asserted-by":"publisher","first-page":"130639","DOI":"10.1155\/2015\/130639","article-title":"Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures","volume":"2015","author":"Malek","year":"2015b","journal-title":"Neural Plast."},{"key":"B66","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejmech.2015.12.036","article-title":"Potent multitarget FAAH-COX inhibitors: design and structure-activity relationship studies","volume":"109","author":"Migliore","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.1016\/j.bmcl.2009.09.033","article-title":"Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands","volume":"19","author":"Morera","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.bmcl.2016.01.071","article-title":"Arylboronic acids as dual-action FAAH and TRPV1 ligands","volume":"26","author":"Morera","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B70","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/jpet.109.164806","article-title":"Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase","volume":"334","author":"Naidu","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1476-5381.2012.02028.x","article-title":"Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system","volume":"167","author":"Okine","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1021\/jm070678q","article-title":"New N-arachidonoylserotonin analogues with potential \u201cdual\u201d mechanism of action against pain","volume":"50","author":"Ortar","year":"2007","journal-title":"J. Med. Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bmcl.2012.10.137","article-title":"Tetrahydro-\u03b2-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels","volume":"23","author":"Ortar","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B74","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.phrs.2006.07.006","article-title":"The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH","volume":"54","author":"Paylor","year":"2006","journal-title":"Pharmacol. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.1171870","article-title":"Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization","volume":"325","author":"Pern\u00eda-Andrade","year":"2009","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/nn0914-1287d","article-title":"Peripheral gating of pain signals by endogenous lipid mediators","volume":"17","author":"Piomelli","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1021\/cn300015x","article-title":"\u201cRedundancy\u201d of endocannabinoid inactivation: new challenges and opportunities for pain control","volume":"3","author":"Piscitelli","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0140-6736(10)60839-2","article-title":"NSAIDs and risk of lower gastrointestinal bleeding","volume":"376","author":"Rahme","year":"2010","journal-title":"Lancet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1053\/j.gastro.2007.06.058","article-title":"Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs","volume":"133","author":"Ray","year":"2007","journal-title":"Gastroenterology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0304-3959(97)00213-3","article-title":"Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors","volume":"75","author":"Richardson","year":"1998","journal-title":"Pain"},{"key":"B81","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2003.10.001","article-title":"[3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution","volume":"995","author":"Roberts","year":"2004","journal-title":"Brain Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1096\/fj.15-270637","article-title":"Multitarget fatty acid amide hydrolase\/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage","volume":"29","author":"Sasso","year":"2015","journal-title":"FASEB J."},{"key":"B83","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0304-3940(02)01366-6","article-title":"Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism","volume":"338","author":"Seidel","year":"2003","journal-title":"Neurosci. Lett."},{"key":"B84","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.neuroscience.2005.08.005","article-title":"Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons","volume":"136","author":"Singh Tahim","year":"2005","journal-title":"Neuroscience"},{"key":"B85","doi-asserted-by":"publisher","first-page":"33157","DOI":"10.1074\/jbc.271.52.33157","article-title":"Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2","volume":"271","author":"Smith","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1017\/S1092852900000213","article-title":"Multifunctional drugs: a novel concept for psychopharmacology","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr."},{"key":"B87","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejphar.2013.01.075","article-title":"Non-psychotropic analgesic drugs from the endocannabinoid system: \u201cmagic bullet\u201d or \u201cmultiple-target\u201d strategies?","volume":"716","author":"Starowicz","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"13739","DOI":"10.1523\/JNEUROSCI.3258-07.2007","article-title":"Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways","volume":"27","author":"Starowicz","year":"2007","journal-title":"J. Neurosci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e60040","DOI":"10.1371\/journal.pone.0060040","article-title":"Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism","volume":"8","author":"Starowicz","year":"2013","journal-title":"PLoS ONE"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1021\/jm0495071","article-title":"Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist","volume":"48","author":"Swanson","year":"2005","journal-title":"J. Med. Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000324070","article-title":"Cannabinoids for pain management","volume":"30","author":"Thaler","year":"2011","journal-title":"Adv. Psychosom. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1744-8069-6-16","article-title":"Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain","volume":"6","author":"Toth","year":"2010","journal-title":"Mol. Pain"},{"key":"B93","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1213\/01.ane.0000194587.94260.1d","article-title":"The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac","volume":"102","author":"Ulug\u00f6l","year":"2006","journal-title":"Anesth. Analg."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1038\/sj.emboj.7600784","article-title":"Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels","volume":"24","author":"Van der Stelt","year":"2005","journal-title":"EMBO J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1194\/jlr.M500374-JLR200","article-title":"Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2","volume":"46","author":"Yang","year":"2005","journal-title":"J. Lipid Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T08:10:44Z","timestamp":1473235844000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2016.00257\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":97,"URL":"https:\/\/doi.org\/10.3389\/fphar.2016.00257","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]}}}